Cost-effectiveness of Implementing a Genotype-Guided De-Escalation Strategy in Patients with Acute Coronary Syndrome.
van den Broek WWA, Azzahhafi J, Chan Pin Yin DRPP, van der Sangen NMR, Sivanesan S, Dijksman LM, Walhout RJ, Gin MTJ, Breet NJ, Langerveld J, Vlachojannis GJ, van Bommel RJ, Appelman Y, van Schaik RHN, Henriques JPS, Kikkert WJ, Ten Berg JM.
van den Broek WWA, et al. Among authors: dijksman lm.
Eur Heart J Cardiovasc Pharmacother. 2024 Nov 13:pvae087. doi: 10.1093/ehjcvp/pvae087. Online ahead of print.
Eur Heart J Cardiovasc Pharmacother. 2024.
PMID: 39537191